online pharmacy homeabout uspricesrefillordersupportcontact
online pharmacy

Weight Loss


Women's Health


Men's Health


Sexual Health


Skin Care


Pain Relief


Heart and Hypertension Treatment


Quit Smoking


Antibiotics


Muscle Relaxers


Allergy Relief


Anti-Depressants


Asthma Treatment


Lower Cholesterol


Heartburn Treatment


Diabetes Treatment


Miscellaneous



Buy Advair

Buy Advair

Advair

Asthma treatment
Advair Diskus is used long term to prevent asthma in patients 12 and older. Advair is not used to relieve sudden asthma attacks. Advair is the first and only preventative asthma product to treat the two main components of asthma, airway constriction and inflammation. Advair is a Fluticasone Propionate/Salmeterol Xinafoate Inhalation Powder. Buy Advair from us- we have the best prices guaranteed!

Advair price



Advair Uses

Advair is used long term to prevent asthma in patients 12 and older. Advair is not used to relieve sudden asthma attacks.




Advair How To Take

Advair (Fluticasone and salmeterol) comes as a powder to inhale only by mouth using a special inhaler device. It usually is used twice daily, in the morning and evening approximately 12 hours apart. Follow the directions on your Advair prescription label carefully, and ask your pharmacist or doctor to explain any part you do not understand.

Use Advair exactly as directed. Do not use more or less Advair or use Advair more often than prescribed by your doctor. Advair controls asthma but does not cure it. It may take one week or longer before you feel the full benefit of Advair. Continue to use Advair even if you feel well. Do not stop using Advair without consulting with your doctor. Before you use Advair inhalation for the first time, read the written instructions that come with it. Ask your doctor, pharmacist, or respiratory therapist to show you how to use the inhaler. Practice using your inhaler while he or she watches.

To use the Advair inhaler, follow these steps:

  • Hold the Advair inhalation device in one hand, and put the thumb of your other hand on the thumbgrip. Push your thumb away from you as far as it will go until the mouthpiece appears and snaps into position.
  • Hold the Advair inhalation device in a horizontal position with the mouthpiece towards you. Slide the lever away from you as far as it will go until it clicks.
  • Every time the lever is pushed back, a dose of Advair is ready to inhale. You will see the number in the dose counter go down. Do not waste doses by closing the device, playing with the lever, or advancing the lever more than once.
  • Hold the Advair inhalation device level and away from your mouth, and breathe out as far as you comfortably can.
  • Put the mouthpiece to your lips. Breathe in deeply and quickly though the inhalation device and not through your nose.
  • Remove the Advair inhalation device from your mouth, and hold your breath for 10 seconds or as long as you comfortably can. Breathe out slowly.
  • Put your thumb on the thumbgrip and slide it back toward you as far as it will go. The device will click shut.
  • Rinse your mouth with water. Never exhale into the inhalation device. Never take the device apart. Never wash the mouthpiece or any part of the device.
  • Keep the device dry.
  • Do not use the device with a spacer.



  • Advair Side Effects

    Advair may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away: runny nose, sneezing, sore throat, hoarseness, sinus pain, cough, headache, upset stomach, vomiting, diarrhea, stomach pain, muscle and bone pain. Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately: hives, skin rash, itching, swelling of the face, throat, tongue, lips, hands, feet, ankles, or lower legs, choking or difficulty swallowing, increased difficulty breathing, less relief from your short-acting inhaler, need to use more puffs of your short-acting inhaler or need to use it more often, decrease in peak flow measurements, pounding or fast heartbeat, chest pain, nervousness, tremor, restlessness, loss of vision, white patches in the mouth. Advair (Fluticasone and salmeterol) may cause children to grow more slowly. If you think that your child who is using fluticasone and salmeterol is not growing properly, talk to your child's doctor. Advair (Fluticasone and salmeterol) may cause other side effects. Call your doctor if you have any unusual problems while using this Advair.




    Advair Medical Precautions

    Tell your doctor and pharmacist if you are allergic to fluticasone (Flonase, Flovent), salmeterol (Serevent), or any other medications. Do not take formoterol (Foradil), salmeterol (Serevent), or regularly scheduled (for example, four-times-a-day) short-acting beta-agonists such as albuterol (Proventil, Ventolin) while taking Advair (fluticasone and salmeterol). Tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: antifungals such as fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); beta-blockers such as atenolol (Tenormin), labetalol (Normodyne), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Inderal); cimetidine (Tagamet); clarithromycin (Biaxin); cyclosporine (Neoral, Sandimmune); danazol (Danocrine); delavirdine (Rescriptor); diltiazem (Cardizem, Dilacor, Tiazac); diuretics (water pills); erythromycin (E.E.S., E-Mycin, Erythrocin); fluoxetine (Prozac, Sarafem); fluvoxamine (Luvox); HIV protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir); isoniazid (INH, Nydrazid); metronidazole (Flagyl); nefazodone (Serzone); oral contraceptives (birth control pills); troleandomycin (TAO); verapamil (Calan, Covera, Isoptin, Verelan); and zafirlukast (Accolate). Also tell your doctor and pharmacist if you are taking the following medications or have stopped taking them during the past 2 weeks: antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); and monoamine oxidase (MAO) inhibitors, including phenelzine (Nardil) and tranylcypromine (Parnate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Tell your doctor if you have or have ever had heart or liver disease, high blood pressure, convulsions, an overactive thyroid (hyperthyroidism), diabetes, or tuberculosis, and if you have a herpes eye infection or a fungal, viral, or bacterial infection (except an infection of the skin). Tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using Advair )fluticasone and salmeterol), call your doctor. If you are having surgery, including dental surgery, tell your doctor or dentist that you are taking Advair(fluticasone and salmeterol). Do not use Advair (fluticasone and salmeterol) during a sudden asthma attack. You should have a fast-acting inhaler such as albuterol (Proventil, Ventolin) to use during asthma attacks. Avoid exposure to chickenpox or measles. If you are exposed to these diseases, call your doctor immediately. You may need to get a vaccine to protect you from these infections.




    Advair Drug Interactions

    Drug interactions can result in unwanted side effects or prevent a medicine from doing its job. Use our drug interaction checker to find out if your medicines interact with each other. Check drug interactions.




    Advair Medical Notes

    Contact your health care provider at once if you feel you have used too much Advair.




    Advair Missed Dosages

    Take the missed Advair dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double doseof Advair to make up for a missed one.




    Advair Storage

    Keep Advair in the container it came in, tightly closed, and out of reach of children. Store Advair at room temperature and away from excess heat and moisture (not in the bathroom). Throw away the Advair inhalation device 1 month after you remove it from the foil overwrap or after every blister has been used (when the dose indicator reads 0), whichever comes first. Talk to your pharmacist about the proper disposal of your medication.




    Advair Extra

    Advair Diskus News

    FDA Approves Advair Diskus (fluticasone propionate/salmeterol) Treatment for COPD Associated with Chronic Bronchitis RESEARCH TRIANGLE PARK, NC -- November 18, 2003 -- The U.S. Food and Drug Administration (FDA) has approved Advair DiskusŪ 250/50 as a new treatment for a serious lung disease that affects millions of Americans - chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis. This is the first time that a product containing both an anti- inflammatory (fluticasone propionate) and a long-acting bronchodilator (salmeterol) has been approved for this condition.

    COPD, which includes chronic bronchitis and emphysema, is a complex lung disease that has several components: inflammation, bronchoconstriction and structural changes in the airways that restrict airflow into and out of the lungs. It is a debilitating and progressive condition that results in a loss of lung function.

    Until now, the only medications approved for the treatment of COPD associated with chronic bronchitis have been bronchodilators. Many COPD patients with chronic bronchitis need multiple medications to help manage their condition. Advair Diskus contains two medicines which work in different ways to improve lung function - a key goal of COPD therapy. In a clinical study, Advair Diskus 250/50 showed significantly greater improvement in lung function than the leading long-acting bronchodilator (salmeterol) used alone.

    Advair Diskus 250/50 is indicated for the twice daily, maintenance treatment of airflow obstruction in patients with COPD associated with chronic bronchitis. It does not replace fast-acting inhalers used to relieve sudden symptoms of shortness of breath.

    "The approval of Advair Diskus 250/50 for this condition is important news for patients and physicians," said William Bailey, MD, professor of medicine and director of the Lung Health Center at the University of Alabama- Birmingham. "There is growing recognition that COPD is a complex disease with multiple components. Advair offers a new approach, because it contains both an anti-inflammatory and a bronchodilator that work together to improve lung function." The two medications are combined in one breath-activated inhaler called the Diskus, which contains a built-in dose counter. Advair Diskus may make treatment more convenient: patients take just one inhalation twice a day, whereas some other treatments can require up to three inhalations four times a day.

    Background on COPD

    More than 20 million Americans are estimated to have COPD(1), and most have associated chronic bronchitis. In COPD, airways become inflamed (swollen and irritated) and clogged with mucus, which narrows the airways and makes it more difficult to breathe. At the same time, muscles around the airways constrict (bronchoconstriction), which squeezes the airways and makes them even narrower. Long-term exposure to irritants such as tobacco smoke or air pollution is the most frequent cause of COPD. A patient with COPD is considered to have associated chronic bronchitis when he or she has a productive cough on most days for a minimum of three months for at least two successive years, or for six months in one year.(2)

    Clinical Data

    The FDA approved Advair Diskus 250/50 for the treatment of COPD associated with chronic bronchitis based on data that includes the results of a clinical trial involving 723 patients. This 24-week study demonstrated that Advair Diskus 250/50 provided patients with significantly greater improvements in lung function (FEV1) than either of its component medications used alone at the same doses or placebo. Improvement in lung function - an important goal of COPD therapy - occurred after the first dose of Advair Diskus; lung function continued to improve in subsequent weeks. At endpoint, there was a significantly greater improvement in two-hour post-dose FEV1 in patients taking Advair Diskus 250/50 (27 percent, 281 mL) compared with those taking salmeterol (19 percent, 200 mL), fluticasone propionate (14 percent, 147 mL) or placebo (six percent, 58 mL).

    The most common side effects observed in this clinical study with Advair Diskus 250/50 were headache, candidiasis (oral thrush), musculoskeletal pain, throat irritation, lower viral respiratory tract infection and hoarseness. Patients treated with Advair Diskus 250/50 did not have a significant reduction in chronic bronchitis symptoms (as measured by the chronic bronchitis symptom questionnaire) or COPD exacerbations compared with patients treated with placebo over the 24 weeks of therapy. The benefits of treatment of patients with COPD associated with chronic bronchitis with Advair Diskus 250/50 for periods of longer than six months has not been established.

    The Diskus Device

    Unlike traditional aerosol inhalers, which propel medication at a high velocity, the Diskus device is breath-activated: patients use their own breath to inhale pre-measured doses of medication. Each Diskus device contains a 30- day supply of medication and has a built-in dose counter to help patients keep track of doses. In a study of patients with obstructive lung disease, the Diskus device was shown to deliver consistent and accurate doses of medication across a wide range of inhalation levels, even in patients with severely compromised lung function.(3)

    Additional Important Product Information

    In patients with major risk factors for decreased bone mineral content, such as tobacco use, advanced age, sedentary lifestyle, poor nutrition, family history of osteoporosis, or chronic use of drugs that can reduce bone mass (e.g., anticonvulsants and corticosteroids), Advair Diskus may pose an additional risk. Patients should talk with their doctor about ways to reduce their risk. Long-term use of inhaled corticosteroids, including fluticasone propionate, a component of Advair Diskus, may increase the risk of some eye problems (cataracts or glaucoma). Regular eye examinations should be considered. Advair Diskus 250/50 mcg twice daily is the only approved dosage for the treatment of patients who have COPD associated with chronic bronchitis. Higher doses, including Advair Diskus 500/50, are not recommended as no additional improvement in lung function was observed in clinical trials, and higher doses of inhaled corticosteroids increase the risk of systemic effects.


  • Best Prices Advair Pill Online 
  • Discount Advair Online Pharmacy Prices 
  • Advair 50 Mcg 
  • Have a question? Need support?
    Home     About Us     Prices